CP-91149 (CAS No. 186392-40-5) is a small peptide antagonist of the chemokine receptor CXCR3. This compound shows potential as a therapeutic agent for inflammatory disorders, including inflammatory bowel disease, psoriasis, and multiple sclerosis. CP-91149 exerts its effects by reducing the infiltration of immune cells into inflamed tissues. This article aims to provide a comprehensive overview of CP-91149, including its chemical information, health benefits, potential effects, product mechanism, safety, side effects, dosing information, and more.
Chemical Information:
Chemical name: (2S)-1-[(3R)-3-[({[(2R)-2-[4-(4-Fluorobenzoyl)piperazin-1-yl]propan-2-yl]amino}-carbonyl)amino]-4-oxoazetidin-2-yl]-N-(2-methylphenyl)methanesulfonamide Molecular formula: C27H32FN5O5S Formula weight: 567.64 g/mol CAS No: 186392-40-5
Top Ten Keywords from Google:
Synonyms Synonym:
· N-[(2S)-1-[[3-(2-methylphenylsulfonamido)-3-oxopropyl]amino]-4-oxo-2-azetidinyl]-4-fluorobenzamide L-tartarate (1:2) · CP91149
Health Benefits of CP-91149:
CP-91149 shows potential as a therapeutic agent for inflammatory disorders, such as inflammatory bowel disease, psoriasis, and multiple sclerosis. The benefits of CP-91149 include:
Reduced Inflammation: CP-91149 works by reducing the infiltration of immune cells into inflamed tissues. This compound can help to reduce inflammation, which is a common feature of many inflammatory disorders.
Normalization of the Immune Response: By reducing the infiltration of immune cells into inflamed tissues, CP-91149 can help to normalize the immune response. This normalization can help to prevent the overactivation of the immune system, which can contribute to inflammatory disorders.
Potential Effects of CP-91149:
CP-91149 has the potential to produce a wide range of effects on the body. Some of the potential effects of this medication include:
Reduced Inflammation: CP-91149 works by reducing the infiltration of immune cells into inflamed tissues. This compound can help to reduce inflammation and other symptoms associated with inflammatory disorders.
Normalization of the Immune Response: By reducing the infiltration of immune cells into inflamed tissues, CP-91149 can help to normalize the immune response. This normalization can help to prevent the overactivation of the immune system, which can contribute to inflammatory disorders.
Product Mechanism:
CP-91149 is a small peptide antagonist of the chemokine receptor CXCR3. This receptor plays an important role in the recruitment and migration of immune cells to inflamed tissues. By inhibiting the action of CXCR3, CP-91149 can reduce the infiltration of immune cells into inflamed tissues. This, in turn, can help to reduce inflammation and other symptoms associated with inflammatory disorders.
Safety of CP-91149:
CP-91149 is generally considered to be safe, although it may produce side effects in some patients. Before taking this medication, individuals should speak to their doctor to discuss any potential risks and side effects.
Side Effects of CP-91149:
Some of the potential side effects of CP-91149 may include:
Dosing Information:
The dosing regimen for CP-91149 may vary depending on the patient's individual needs and medical history. Patients should speak to their doctor to determine the appropriate dosage and schedule.
Conclusion:
CP-91149 (CAS No. 186392-40-5) is a small peptide antagonist of the chemokine receptor CXCR3. This compound shows potential as a therapeutic agent for inflammatory disorders, including inflammatory bowel disease, psoriasis, and multiple sclerosis. By reducing the infiltration of immune cells into inflamed tissues, CP-91149 can help to reduce inflammation and other symptoms associated with inflammatory disorders. Although this medication is generally considered to be safe, patients should discuss any potential risks and side effects with their doctor before starting treatment. Overall, CP-91149 is a promising tool in the fight against inflammatory disorders, and it has the potential to improve the lives of countless individuals around the world.
